دورية أكاديمية

A Descriptive Study on the Clinical Profile and Outcomes of Patients with COVID-19 and Tuberculosis Co-infection.

التفاصيل البيبلوغرافية
العنوان: A Descriptive Study on the Clinical Profile and Outcomes of Patients with COVID-19 and Tuberculosis Co-infection.
المؤلفون: Benedicto JP; Division of Pulmonary Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines Manila., Cruz EJM; Division of Pulmonary Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines Manila., Quinto ML; Division of Pulmonary Medicine, Department of Medicine, Philippine General Hospital, University of the Philippines Manila.
المصدر: Acta medica Philippina [Acta Med Philipp] 2024 May 15; Vol. 58 (8), pp. 42-49. Date of Electronic Publication: 2024 May 15 (Print Publication: 2024).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: College Of Medicine And Institute Of Hygiene University Of The Philipines Country of Publication: Philippines NLM ID: 0312677 Publication Model: eCollection Cited Medium: Internet ISSN: 2094-9278 (Electronic) Linking ISSN: 00016071 NLM ISO Abbreviation: Acta Med Philipp Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Manila : College Of Medicine And Institute Of Hygiene University Of The Philipines
مستخلص: Background: Tuberculosis (TB) control has been a challenge in the country and its overall health impact remains significant. COVID-19 has caused significant morbidity and mortality especially among hospitalized patients. TB and COVID-19 co-infection (COVID-TB) may cause more catastrophic consequences and outcomes among afflicted individuals and management may be daunting. There is limited local data on COVID-TB.
Objectives: The clinical profile of COVID-TB patients who were admitted were described. Comparison of the clinical outcomes was also done versus the general admitted COVID-19 patients without concomitant TB in the same institution. Relevant patient outcomes were reported which included admission to an intensive care unit (ICU), length of hospital stay, and mortality rate.
Methods: This is a descriptive study on the demographics and clinical outcomes of patients admitted in the Philippine General Hospital (PGH) for COVID-19 with TB co-infection from March 2020 to September 2020. We aimed to characterize patients with COVID-TB and analyzed their outcomes.
Results: There was a total of 79 patients who were admitted for COVID-19 (confirmed with RT-PCR) with TB co-infection during the study period. Majority of them were males (70.9%) with a median age of 54 (IQR 42 to 64) years. In terms of TB affliction, 75 (94.9%) patients were identified to have pulmonary tuberculosis. Majority of patients had at least one co-morbid illness with hypertension (16.5%), diabetes mellitus (13.9%), and heart failure (11.4%) as the most common. Respiratory symptoms (dyspnea and cough) were the predominant presenting complaint during hospital admission. Majority of the patients were classified as severe (8 or 10.1%) and critical (36 or 45.57%) COVID-19 disease. Fifty-six (70.9%) were bacteriologically confirmed tuberculosis. Radiologic imaging studies revealed findings consistent with pulmonary tuberculosis in 70 (88.61%) through plain radiograph. Forty-seven underwent HRCT and 46 of these (97.8%) had findings suggestive of PTB. Overall, 61 patients (77%) subsequently required oxygen supplementation. The in-hospital mortality within the study population was 36.7% (29/79) in contrast to the general COVID patients admitted in the same period which revealed significantly less fatality at 17.5% (35/200). The length of hospital stay was found to be 21.1 days ± 14.75 days across all study patients, and with median of 20 days for surviving patients. TB treatment outcomes were tracked in the 50 surviving COVID-19 patients where cure was declared in 8/50 (16%) while 22/50 (44%) successfully completed their six-month treatment regimen.
Conclusions: This study of COVID-TB provides an initial evaluation of the potential association between active TB infection and COVID-19 severity and mortality. The data generated from this study may be a starting point to assess the interaction of these two diseases. Furthermore, bidirectional screening may be recommended even at hospitals' triage areas since both diseases may have similar presentations.
Competing Interests: All authors declared no conflicts of interest.
(© 2024 Acta Medica Philippina.)
References: J Gen Intern Med. 2020 May;35(5):1545-1549. (PMID: 32133578)
J Med Virol. 2021 Jan;93(1):194-196. (PMID: 32687228)
N Engl J Med. 2020 Feb 20;382(8):727-733. (PMID: 31978945)
J Infect. 2020 Aug;81(2):e16-e25. (PMID: 32335169)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
PLoS One. 2020 Jul 30;15(7):e0236618. (PMID: 32730358)
Pathog Glob Health. 2021 Sep;115(6):405-411. (PMID: 34014806)
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21. (PMID: 32446305)
N Engl J Med. 2020 Feb 20;382(8):692-694. (PMID: 31978293)
Front Med (Lausanne). 2021 Aug 24;8:657006. (PMID: 34504847)
Eur Respir J. 2021 Nov 11;58(5):. (PMID: 34446465)
Int J Surg. 2020 Apr;76:71-76. (PMID: 32112977)
Eur Respir J. 2020 Jul 9;56(1):. (PMID: 32457198)
Infect Dis (Lond). 2020 Nov - Dec;52(12):902-907. (PMID: 32808838)
BMJ Glob Health. 2020 Nov;5(11):. (PMID: 33199280)
Ther Adv Infect Dis. 2021 Jun 9;8:20499361211016973. (PMID: 34178322)
PLoS One. 2021 Jun 18;16(6):e0253169. (PMID: 34143810)
فهرسة مساهمة: Keywords: COVID-19; co-infection; tuberculosis
تواريخ الأحداث: Date Created: 20240530 Latest Revision: 20240531
رمز التحديث: 20240531
مُعرف محوري في PubMed: PMC11132287
DOI: 10.47895/amp.vi0.7855
PMID: 38812770
قاعدة البيانات: MEDLINE
الوصف
تدمد:2094-9278
DOI:10.47895/amp.vi0.7855